Volume 206, Issue 3

Search all Breast Cancer Research and Treatment articles

August 2024

22 articles in this issue

Beta-blocker use and breast cancer outcomes: a meta-analysis
Oliver William Scott
Sandar TinTin
J. Mark Elwood
Review Open access 05 June 2024 Pages: 443 - 463
Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey
K. Fairhurst
S. A. McIntosh
Our Citable Collaborators
Preclinical study Open access 10 May 2024 Pages: 465 - 471
Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey
M. Bradbury
MF Savard
SF McGee
Clinical trial 25 April 2024 Pages: 473 - 481
A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC
Gabrielle B. Rocque
Noon Eltoum
Smita Bhatia
Clinical trial Open access 10 June 2024 Pages: 483 - 493
Characteristics and risk factors of axillary lymph node metastasis of microinvasive breast cancer
Soo-Young Lee
Tae-Kyung Yoo
Sae Byul Lee
Clinical trial 25 April 2024 Pages: 495 - 507
Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment?
Maya Lubarsky
Alexandra E Hernandez
Neha Goel
Epidemiology 29 May 2024 Pages: 509 - 517
Part of 1 collection:

Cancer Disparities
Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer
Claire Sathe
Melissa K. Accordino
Dawn L. Hershman
Brief Report 04 May 2024 Pages: 519 - 526
Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis
Ali Hijazi
Mohamed Mohanna
Zeina Nahleh
Research Open access 29 April 2024 Pages: 527 - 541
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study
Yifei Chen
Ruyan Zhang
Guohong Song
Research Open access 06 May 2024 Pages: 543 - 550
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort
Rodrigo Sánchez-Bayona
Alfonso Lopez de Sa
Miguel Martin
Research 04 May 2024 Pages: 551 - 559
Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma
María José Roca Navarro
Jose Mª Oliver Goldaracena
José Ignacio Sánchez Méndez
Research Open access 30 May 2024 Pages: 561 - 573
Part of 1 collection:

Cancer Disparities
Indocyanine green angiography guidance for vascular preservation in skin and nipple sparing mastectomy
Thor S. Stead
Connie Y. Lu
Jennifer S. Gass
Research 25 April 2024 Pages: 575 - 583
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer
Josefien P. van Olmen
A. Marjolein Schrijver
Iris M. C. van der Ploeg
Research Open access 12 June 2024 Pages: 585 - 594
Use of ultrasound and MRI to stage the axilla for breast cancer before and after neoadjuvant chemotherapy prior to targeted sentinel lymphadenectomy
Danielle Brabender
April Ballard
Stephen F. Sener
Research Open access 03 May 2024 Pages: 595 - 602
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study
Matilde Corianò
Chiara Tommasi
Nicolò Matteo Luca Battisti
Research 14 May 2024 Pages: 603 - 614
Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer
Robin Schaffar
Simone Benhamou
Elisabetta Rapiti
Research Open access 30 April 2024 Pages: 615 - 623
Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study
Laura A. Huppert
Samantha Fisch
Michelle E. Melisko
Research Open access 18 June 2024 Pages: 625 - 636
Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study
Shuwei Zhang
Houpu Yang
Shu Wang
Research 10 May 2024 Pages: 637 - 651
Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer
**n Huang
Chang Chen
Yidong Zhou
Research Open access 15 June 2024 Pages: 653 - 666
Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer
Kirin Saint
David Nemirovsky
Ting Bao
Research 07 May 2024 Pages: 667 - 675
Letter to the editor: “Body composition measures as a determinant of alpelisib-related toxicity”
Zeki Surmeli
Letter to the Editor 10 June 2024 Pages: 677 - 677
Expression of Concern to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition
Chonggao Yin
Hongli Li
Weiyi Chen
Editorial Expression of Concern 06 June 2024 Pages: 679 - 679

Volume 206, Issue 3

Beta-blocker use and breast cancer outcomes: a meta-analysis

Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey

Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey

A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC

Characteristics and risk factors of axillary lymph node metastasis of microinvasive breast cancer

Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment?

Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer

Clinico–pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis

Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study

Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort

Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma

Indocyanine green angiography guidance for vascular preservation in skin and nipple sparing mastectomy

Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer

Use of ultrasound and MRI to stage the axilla for breast cancer before and after neoadjuvant chemotherapy prior to targeted sentinel lymphadenectomy

The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study

Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer

Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study

Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study

Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer

Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer

Letter to the editor: “Body composition measures as a determinant of alpelisib-related toxicity”

Expression of Concern to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition

Navigation